Organon To Report First Quarter Results and Host Conference Call on May 5, 2022
April 21 2022 - 7:30AM
Business Wire
Organon (NYSE: OGN), will release its first quarter 2022
financial results on May 5, 2022, prior to the company’s webcast
and conference call scheduled for 8:30 a.m. EDT.
Interested parties may access the live call via webcast on the
Organon website at
https://www.organon.com/investor-relations/events-and-presentations/.
A replay of the webcast will be available approximately two hours
after the conclusion of the live event on the company’s
website.
Institutional investors and analysts interested in participating
in the call must register in advance using conference ID# 6895016
and by clicking on this link:
http://www.directeventreg.com/registration/event/6895016. Following
registration, participants will receive a confirmation email
containing details on how to join the conference call, including
dial-information and a unique passcode and registrant ID.
Pre-registration will allow participants to bypass an operator and
be placed directly into the call.
About Organon Organon is a global healthcare company
formed through a spin-off from Merck & Co., Inc., Rahway, NJ,
USA, (NYSE: MRK) known as MSD outside of the United States and
Canada, to focus on improving the health of women throughout their
lives. Organon has a portfolio of more than 60 medicines and
products across a range of therapeutic areas. Led by the women’s
health portfolio coupled with an expanding biosimilars business and
stable franchise of established medicines, Organon’s products
produce strong cash flows that will support investments in
innovation and future growth opportunities in women’s health. In
addition, Organon is pursuing opportunities to collaborate with
biopharmaceutical innovators looking to commercialize their
products by leveraging its scale and presence in fast growing
international markets.
Organon has a global footprint with significant scale and
geographic reach, world-class commercial capabilities, and
approximately 9,300 employees with headquarters located in Jersey
City, New Jersey.
For more information, visit http://www.organon.com and connect
with us on LinkedIn and Instagram.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220421005089/en/
Media: Karissa Peer (614) 314-8094 Kate Vossen (732) 675-8448
Investor: Jennifer Halchak (201) 275-2711 Edward Barger (267)
614-4669
Organon (NYSE:OGN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Organon (NYSE:OGN)
Historical Stock Chart
From Apr 2023 to Apr 2024